Reozalimab (Ibi318) (Anti-PD-1 & PD-L1)
Gecertificeerd

Reozalimab (Ibi318) (Anti-PD-1 & PD-L1)

Catalog #: C00917
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

CAS Number

2445259-99-2

Synonyms

LY3434172, Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318

SKU

C00917-1mg

Target

PD-1/PD-L1

Applications

Apoptosis

Additionnal Information

Reozalimab (Ibi318) is a first-in-class recombinant IgG1 bispecific antibody that targets both PD-1 and PD-L1, with checkpoint inhibitory, immunostimulating, and antineoplastic activities. It fully blocks the PD-1 pathway, disrupts PD-L1/CD80 interactions, and enhances T cell activation for improved tumor cell killing. M.W 143.84 kDa

Storage Conditions

-80°C (avoid freeze-thaw cycles)

Beschrijving

Reozalimab (Ibi318) (Anti-PD-1 & PD-L1) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamReozalimab (Ibi318) (Anti-PD-1 & PD-L1)
Categorie
Beschikbare grootte1 mg
CatalogusnummerC00917